<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Glp-1 Inflammation on Longetivities</title><link>https://longetivities.com/tags/glp-1-inflammation/</link><description>Recent content in Glp-1 Inflammation on Longetivities</description><generator>Hugo</generator><language>en-us</language><lastBuildDate>Thu, 16 Apr 2026 00:00:00 +0000</lastBuildDate><atom:link href="https://longetivities.com/tags/glp-1-inflammation/feed.xml" rel="self" type="application/rss+xml"/><item><title>GLP-1 Microdosing Longevity: A Practical Guide to Living Longer</title><link>https://longetivities.com/blog/glp-1-microdosing-longevity-a-practical-guide-to-living-longer/</link><pubDate>Wed, 01 Apr 2026 00:00:00 +0000</pubDate><guid>https://longetivities.com/blog/glp-1-microdosing-longevity-a-practical-guide-to-living-longer/</guid><description>&lt;blockquote&gt;
&lt;p&gt;&lt;strong&gt;Cluster context:&lt;/strong&gt; This article belongs to the &lt;strong&gt;Metabolic and Prescription Longevity Drugs&lt;/strong&gt; cluster. For the broader overview, start with &lt;a href="https://longetivities.com/blog/prescription-longevity-drugs-clinical-guide-to-preventive-medicine/"&gt;Prescription Longevity Drugs: Clinical Guide To Preventive Medicine&lt;/a&gt;.&lt;/p&gt;
&lt;/blockquote&gt;
&lt;p&gt;The promise of glp 1 microdosing longevity has captured attention from biohackers and clinicians alike. Originally developed to treat diabetes and obesity, these medications are now being explored at lower doses by healthy adults hoping to promote healthy aging and extend healthspan.&lt;/p&gt;
&lt;p&gt;This guide covers what you need to know: the science behind microdosing, clinical evidence across multiple health domains, potential risks, and practical guidance for those considering this approach.&lt;/p&gt;</description></item></channel></rss>